Status:
UNKNOWN
Vision-based Assessment of Joint Extensibility in Ehlers Danlos Syndrome
Lead Sponsor:
University Health Network, Toronto
Conditions:
Ehlers-Danlos Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Ehlers Danlos Syndrome (EDS) is a heterogenous group of genetic disorders with 13 identified subtypes. Hypermobile EDS (hEDS), although the most common subtype of EDS, does not yet have an identified ...
Eligibility Criteria
Inclusion
- All patients seen in the GoodHope EDS clinic at Toronto General are eligible for inclusion, regardless of their presenting diagnosis or the results of their assessments
Exclusion
- Patients who do not consent to participate will not be included (participants may withdraw consent at any time)
Key Trial Info
Start Date :
April 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05366114
Start Date
April 26 2022
End Date
December 1 2024
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GoodHope EDS - Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4